Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9%
Other Admin

Neurothera Labs Announces Continuance into Ontario

By The Northwire Desk — AI Analysis Apr 30, 2026 · 10:59 NTLX · 0.26 NeuroThera Labs Inc.
NTLX · Price

Executive Summary

  • Neurothera Labs Inc. has officially transitioned its jurisdiction from British Columbia to Ontario under the Business Corporations Act (Ontario).
  • The continuance was approved by shareholders via special resolution at a meeting held on April 10, 2026.

Key Details

  • Jurisdiction Change: Moved from the provincial jurisdiction of British Columbia to the provincial jurisdiction of Ontario (OBCA).
  • Corporate Documents: The Company has replaced its notice of articles and articles with new articles of continuance and by-laws under the OBCA.
  • Unchanged Identifiers: The CUSIP / ISIN numbers for common shares and the stock symbol remain unchanged.
Read the original news release →

More from NeuroThera Labs Inc.

Jun 30, 2026 · 18:00

Pre-revenue neurology and cannabis-tech company raises capital at a discount to fund operations and settle parent company debt.

Financings Jun 03, 2026 · 17:15

Neurothera Closes Cashless Quantum-Tech Acquisition, But Dilution and Clinical Stage Risks Keep Upside Capped

M&A / Property May 27, 2026 · 08:00

Neurothera Labs Confirms Acquisition Closing Amidst Significant Equity Dilution and Regulatory Scrutiny

M&A / Property May 20, 2026 · 17:00

Neurothera Labs Announces Adoption of Semi-Annual Reporting

Other Apr 23, 2026 · 18:00

Neurothera Labs Engages bullVestor for Investor Relations Activities

Other Mar 16, 2026 · 07:31

NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

M&A / Property